Clinical Guidelines
- About
- CCA guidelines
- Barrett’s Oesophagus
- Bowel cancer
- Endometrial cancer
- Cervical cancer screening
- Foreword
- Introduction
- Summary of recommendations
- 1. Cervical cancer in Australia
- 2. The rationale for primary HPV screening
- 3. Terminology
- 4. Unsatisfactory cervical screening results
- 5. Benefits, harms and cost-effectiveness of cervical screening in the renewed NCSP
- 6. Management of oncogenic HPV test results
- 7. Colposcopy
- 8. Management of discordant colposcopic impression, histopathology and referral LBC prediction
- 9. Management of histologically confirmed low-grade squamous abnormalities
- 10. Management of histologically confirmed high-grade squamous abnormalities
- 11. Management of glandular abnormalities
- 12. Screening in Aboriginal and Torres Strait Islander women
- 13. Screening after total hysterectomy
- 14. Screening in pregnancy
- 15. Screening in women who have experienced early sexual activity or have been victims of sexual abuse
- 16. Screening in immune-deficient women
- 17. Screening in DES-exposed women
- 18. Signs and symptoms of cervical cancer
- 19. Psychosocial care
- 20. Transition to the renewed National Cervical Screening Program
- Appendices Explore Cervical cancer screening
- Lung cancer
- Prostate cancer
- Sarcoma
- Skin cancer
- Pain management
- Archive of CCA guidelines See all CCA guidelines
- COSA guidelines
- Other guidelines